Giant Gastric Gastrointestinal Stromal Tumor (GIST)
item.contributor.advisor
ORCID:
Journal Title
Journal ISSN
Volume Title
Publisher
Springer
item.page.isbn
item.page.issn
item.page.issne
item.page.doiurl
item.page.extent
3
item.page.accessRights
item.page.other
item.page.references
Abstract
Gastrointestinal stromal tumors (GIST) represent 0.1–3 % of gastrointestinal malignancy. Surgery is the mainstay of treatment, but in high-risk tumors, imatinib can help to achieve better oncological ...
Description
item.page.coverage.spatial
item.page.sponsorship
Citation
J Gastrointest Surg (2017) 21:202-204
item.page.dc.rights
item.page.dc.rights.url
Estadísticas de uso
1 0,8 0,5 0,3 0
Agosto 2025Septiembre 2025Octubre 2025Noviembre 2025Diciembre 2025Enero 2026Febrero 2026